51 results
424B5
XENE
Xenon Pharmaceuticals Inc.
30 Nov 23
Prospectus supplement for primary offering
4:18pm
shares, or issue shares upon exercise or conversion of related securities, pursuant to any stock option, stock bonus or other stock plan or arrangement
8-K
EX-1.1
XENE
Xenon Pharmaceuticals Inc.
30 Nov 23
Entry into a Material Definitive Agreement
4:15pm
and the Prospectus. The descriptions of the Company’s stock option, stock bonus and other stock plans or arrangements, and the options or other rights … or options to purchase Shares, or issue Shares upon exercise or conversion of Related Securities, pursuant to any stock option, stock bonus or other stock
424B5
XENE
Xenon Pharmaceuticals Inc.
29 Nov 23
Prospectus supplement for primary offering
5:05pm
to any stock option, stock bonus or other stock plan or arrangement or other related securities described herein, provided that, in the case of options
8-K
EX-1.1
wcmj2hnx
23 Jun 22
Other Events
4:04pm
8-K
EX-1.1
x6btum3j
6 Oct 21
Other Events
4:50pm
8-K
EX-1.1
lazng txg0gk
10 Mar 21
Other Events
5:24pm
8-K
EX-10.3
qqvj1muue9jz i81c
14 Jan 21
Topline Data from XEN1101 Phase 2b X-TOLE Clinical Trial in Adult Focal Epilepsy on Track for Third Quarter of 2021
8:05am
8-K
EX-10.2
q71d 1b3f
14 Jan 21
Topline Data from XEN1101 Phase 2b X-TOLE Clinical Trial in Adult Focal Epilepsy on Track for Third Quarter of 2021
8:05am
8-K
EX-10.4
igk63yl8t46 6e
14 Jan 21
Topline Data from XEN1101 Phase 2b X-TOLE Clinical Trial in Adult Focal Epilepsy on Track for Third Quarter of 2021
8:05am
8-K
t5d78vf0a8036
14 Jan 21
Topline Data from XEN1101 Phase 2b X-TOLE Clinical Trial in Adult Focal Epilepsy on Track for Third Quarter of 2021
8:05am
8-K
EX-1.1
nct479dkhact0hlu41u
6 Aug 20
Entry into a Material Definitive Agreement
4:56pm